ADVENTRX Pharmaceuticals Income Statement
View: Annual | Quarterly
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07* |
|
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 |
| Cost of Goods Sold | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 6.3 | 6.0 | 6.7 | 6.5 | 6.5 |
| Depreciation & Amortization | (0.1) | (0.2) | (0.2) | (0.2) | (0.2) |
| Operating Income | (6.2) | (5.8) | (6.4) | (6.3) | (5.8) |
| Operating Margin | -- | -- | -- | -- | -- |
| Nonoperating Income | 0.3 | 0.4 | 0.5 | 0.6 | 0.6 |
| Nonoperating Expenses | -- | -- | -- | -- | -- |
| Income Before Taxes | (5.9) | (5.4) | (5.9) | (5.7) | (5.1) |
| Income Taxes | -- | -- | -- | -- | -- |
| Net Income After Taxes | (5.9) | (5.4) | (5.9) | (5.7) | (5.1) |
| Continuing Operations | (5.9) | (5.4) | (5.9) | (5.7) | (5.1) |
| Discontinued Operations | -- | -- | -- | -- | -- |
| Total Operations | (5.9) | (5.4) | (5.9) | (5.7) | (5.1) |
| Total Net Income | (5.9) | (5.4) | (5.9) | (5.7) | (5.1) |
| Net Profit Margin | -- | -- | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (0.07) | (0.06) | (0.07) | (0.06) | (0.06) |
| Dividends per Share | -- | -- | -- | -- | -- |






